Tetra Radar · FDA Approvals · Decision date

lorundrostat: FDA decision date

Mineralys Therapeutics, Inc. (MLYS) · 22 December 2026

The FDA accepted the NDA submission and provided us with a Prescription Drug User Fee Act (PDUFA) target date of December 22, 2026 for lorundrostat.

Source: 10-Q of 4 November 2026

The decision is pending.

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.